Improving Quality of Care for Sickle Cell Patients in the Pediatric Emergency Department

Susan M Lin1, John J Strouse, Lauren N Whiteman

  • 1From the *Department of Medicine, and †Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, MD.

Insights

Pediatric patients with sickle cell pain crises face treatment delays. Earlier pain management shortens emergency department stays but does not impact overall hospitalization length.

Area of Science:

  • Pediatric Emergency Medicine
  • Hematology
  • Pain Management

Background:

  • Sickle cell pain crisis is a common reason for pediatric emergency department visits.
  • Delays in pain management can negatively impact patient outcomes.
  • Understanding factors contributing to delays is crucial for improving care.

Purpose of the Study:

  • To identify factors associated with delayed treatment for sickle cell pain crisis in pediatric emergency departments.
  • To determine if earlier pain management correlates with better clinical outcomes.

Main Methods:

  • Retrospective study of 160 sickle cell pain crisis visits in patients aged 21 years or younger.
  • Data extracted from electronic records included demographics, clinical characteristics, and timestamps for care milestones.
  • Analysis focused on time to initial analgesic administration and pain reassessment.

Main Results:

  • Mean time to initial analgesic administration was 89 minutes; to pain reassessment was 60 minutes.
  • Imaging orders and higher triage pain scores were associated with delays and faster treatment, respectively.
  • Earlier pain management reduced emergency department length of stay but not total hospitalization duration.

Conclusions:

  • Significant delays in initial analgesic administration for pediatric sickle cell pain crises were observed.
  • A standardized pain management approach could enhance emergency department care for sickle cell crises.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
502
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
687
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
360
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
505